Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-11-21
2006-11-21
Benzion, Gary (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S091200
Reexamination Certificate
active
07138507
ABSTRACT:
The present invention relates to prognostic methods which are useful in medicine, particularly cancer chemotherapy. The object of the invention to provide a method for assessing GST-pi expression levels in fixed or fixed and paraffin embedded tissues and prognosticate the probable resistance or sensitivity of a patient's tumor to treatment with platinum-based therapies by examination of the amount of GST-pi mRNA in a patient's tumor cells and comparing it to a predetermined threshold expression level. More specifically, the invention provides to oligonucleotide primer pair GST-piand methods comprising their use for detecting levels of GST-pi mRNA.
REFERENCES:
patent: 4830969 (1989-05-01), Holmes
patent: 4843155 (1989-06-01), Chomczynski
patent: 5128247 (1992-07-01), Koller
patent: 5204241 (1993-04-01), Pero
patent: 5284940 (1994-02-01), Lin et al.
patent: 5346994 (1994-09-01), Chomczynski
patent: 5502166 (1996-03-01), Mishina
patent: 5620852 (1997-04-01), Lin et al.
patent: 5637687 (1997-06-01), Wiggins
patent: 5643767 (1997-07-01), Fischetti et al.
patent: 5654179 (1997-08-01), Lin
patent: 5672696 (1997-09-01), Wang et al.
patent: 5707802 (1998-01-01), Sandhu et al.
patent: 5728822 (1998-03-01), Macfarlane
patent: 5777099 (1998-07-01), Mehra
patent: 5942389 (1999-08-01), Kirschling et al.
patent: 5945515 (1999-08-01), Chomczynski
patent: 5989857 (1999-11-01), Mundschenk
patent: 6010700 (2000-01-01), Richt
patent: 6043354 (2000-03-01), Hillebrand et al.
patent: 6136605 (2000-10-01), Fahl et al.
patent: 6248535 (2001-06-01), Danenberg et al.
patent: WO 95/28489 (1995-10-01), None
patent: WO 97/05248 (1997-02-01), None
patent: WO 97/35034 (1997-09-01), None
patent: WO 98/41648 (1998-09-01), None
patent: WO 01/46402 (2001-06-01), None
patent: WO 02/44423 (2002-06-01), None
GenBank Accession Nos. U30897, U62589 May 9, 1997.
Sequence Search Results US-10-654-575.
Ali-Osman et al. “Molecular Cloning, Characterization, and Expression inEscherichia coliof Full-length cDNA of Three Human Glutathione S-Transferase Pi Gene Variants” The Journal of Biological Chemistry. Apr. 11, 1997. vol. 272 No. 15, pp. 10004-10012.
Buck et al, “Design strategies and performance of custom DNA sequencing primers”, Biotechniques (1999) 27:528-536.
Stanta et al. (Methods in Mol. Biology (1998) 86:113-9).
Hillier, L. et al., “The WashU-Merck EST project”, Database EMBL ′Online!European Molecular Biological Laboratory; Jul. 27, 1995, XP002315145, Database accession No. H39177, abstract.
Gaoming, C. et al., “Quantitation of GST-PI MRNA Expression by Polymerase Chain Reaction”,Zhongguo Zhongliu Linchuang—Chinese Journal of Clinical Oncology, vol. 25, 1998, pp. 858-861, XP008040058, abstract.
Ardalan, B., et al., “Thymidylate Synthase Gene Expression in Normal and Malignant Colorectal Tissues: Relation to in vivo Response and Survival,” Proceedings of the American Association for Cancer Research, vol. 37, Abstract No. 1376 (Mar. 1996).
Ausubel, F.M., ed.,Current Protocols In Molecular Biology, John Wiley & Sons, Inc., vol. 1.; Strauss, W. M., “Preparation of Genomic DNA from Mammalian Tissue,” Unit 2.2, pp. 2.2.1-2.2.3 (1998).
Ausubel, F.M., ed.,Current Protocols In Molecular Biology, John Wiley & Sons, Inc., vol. 1.; Richards, E., et al., “Preparation of Genomic DNA from Plant Tissue,” Unit 2.3, pp. 2.3.1-2.3.7 (1994).
Ausubel, F.M., ed.,Current Protocols In Molecular Biology, John Wiley & Sons, Inc., vol. 1.;Wilson, K., “Preparation of Genomic DNA from Bacteria,” Unit 2.4, pp. 2.4.1-2.4.5 (1994).
Banerjee, S.K., et al, “Microwave-Based DNA Extraction from Paraffin-Embedded Tissue for PCR Amplification,” BioTechniques, vol. 18, No. 5, pp. 768, 770, 772, 773 (1995).
Benhattar, J., et al., “p53 Mutations as a Possible Predictor of Response to Chemotherapy in Metastatic Colorectal Carcinomas,” Int. J. Cancer (Pred. Oncol.), vol. 69, pp. 190-192 (1996).
Bresters, D., et al., “Detection of Hepatitis C Viral RNA Sequences in Fresh and Paraffin-Embedded Liver Biopsy Specimens of Non-A, Non-B Hepatitis Patients,” J. Hepat., vol. 15, pp. 391-395 (1992).
Bresters, D., et al., “The Duration of Fixation Influences the Yield of HCV cDNA-PCR Products from Formalin-Fixed, Paraffin-Embedded Liver Tissue,” J. Virol. Method, vol. 48, pp. 267-272 (1994).
Chirgwin, J., M., et al., “Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease,” Biochemistry, vol. 18, No. 24, pp. 5294-5299 (1979).
Chomczynski, P., et al., “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,” Analytical Biochemistry, vol. 162, pp. 156-159 (1987).
Chomczynski, P., “A Reagent for the Single-Step Simultaneous Isolation of RNA, DNA and Proteins from Cell and Tissue Samples,” BioTechniques, vol. 15, No. 3, pp. 532-534, 536-537 (1993).
Coombs, N. J., et al., “Opimisation of DNA and RNA Extraction from Archival Formalin-Fixed Tissue,” Nucl. Acids Research, vol. 27, No. 16, pp. i-iii (1999).
Dakhama, A., et al., “Amplification of Human β-Actin Gene by the Reverse Transcripase-Polymerase Chain Reaction: Implications for Assessment of RNA from Formalin-Fixed, Paraffin-Embedded Material,” J. Histochem. and Cytochem., vol. 44, No. 10, pp. 1205-1207 (1996).
de Andrés, B., et al., “Improved Method for mRNA Extraction from Paraffin-Embedded Tissues,” BioTechniques, vol. 18, No. 1, pp. 42-43 (1995).
Eads, C. A., et al., “CpG Island Hypermethylation in Human Colorectal Tumors is Not Associated with DNA Methyltransferase Overexpression,” Cancer Research, vol. 59, pp. 2302-2306 (1999).
Edamoto, Y., et al., “Hepatitis C and B Virus Infections in Hepatocellular Carcinoma,” CANCER, vol. 77, No. 9, pp. 1787-1791 (1996).
Finke, J., et al., “An Improved Strategy and a Useful Housekeeping Gene for RNA Analysis from Formalin-Fixed, Paraffin-Embedded Tissues by PCR,” BioTechniques, vol. 14, No. 3, pp. 448-453 (1993).
Goldsworthy, S. M., et al., “Effects of Fixation on RNA Extraction and Amplification from Laser Capture Microdissected Tissue,” Molecular Carcinogenesis, vol. 25, pp. 86-91 (1999).
Greer, C. E., et al., “PCR Amplification from Paraffin-Embedded Tissues,” Am. J. Clin. Pathol., vol. No. 95, No. 2, pp. 117-124 (1991).
Gruber, A. D., et al., “Detection of Bovine Viral Diarrhea Virus RNA in Formalin-Fixed, Paraffin-Embedded Brain Tissue by Nested Polymerase Chain Reaction,” J. Virol. Methods, vol. 43, pp. 309-319 (1993).
Guerrero, R.B., et al., “Effects of Formalin Fixation and Prolonged Block Storage on Detection of Hepatitis C Virus RNA in Liver Tissue,” Diag. Molec. Path., vol. 6, No. 5, pp. 277-281 (1997).
Heid, C. A., et al., “Real Time Quantitative PCR,” Genome Research, vol. 6, pp. 986-994 (1996).
Hodges, E., et al., “Isolation of Nucleic Acid from Paraffin Embedded Tissue for PCR Amplification and Sequencing of TcR Vβ Genes,” Leuk. Research, vol. 19, No. 3, pp. 183-186 (1995).
Horie, N., et al., “Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5′ terminal Regulatory Region of the Human Gene for Thymidylate Synthase,” Cell Structure and Function, vol. 20, No. 3, pp. 191-197 (1995).
Horikoshi, T., et al., “Quantitation of Thymidylate Synthase, Dihydrofolate Reductase, and DT-Diaphorase Gene Expression in Human Tumors using the Polymerase Chain Reaction,” Cancer Res., vol. 52, pp. 108-116 (1992).
Hsuih, T. C. H., et al., “Novel, Ligation-Dependent PCR Assay for Detection of Hepatitis C Virus in Serum,” J. Clin. Microbiol., vol. 34, No. 3, pp. 501-507 (1996).
Ichikawa, W., et al., “Expression of Dihydropyrimidine Dehydrogenase(DPD)and Thymidylate Synthase(TS)mRNA in Primary Tumor Predict
Babic Christopher M
Benzion Gary
Kenyon & Kenyon
Response Genetics, Inc.
LandOfFree
Method of determining a chemotherapeutic regimen based on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining a chemotherapeutic regimen based on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining a chemotherapeutic regimen based on... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681570